[go: up one dir, main page]

AR080289A1 - IODO PRECURSOR AGENT FOR OBTAINING PET IMAGES FROM AMYLOID PLATES - Google Patents

IODO PRECURSOR AGENT FOR OBTAINING PET IMAGES FROM AMYLOID PLATES

Info

Publication number
AR080289A1
AR080289A1 ARP110100377A ARP110100377A AR080289A1 AR 080289 A1 AR080289 A1 AR 080289A1 AR P110100377 A ARP110100377 A AR P110100377A AR P110100377 A ARP110100377 A AR P110100377A AR 080289 A1 AR080289 A1 AR 080289A1
Authority
AR
Argentina
Prior art keywords
pet images
precursor agent
obtaining pet
amyloid
iodo
Prior art date
Application number
ARP110100377A
Other languages
Spanish (es)
Inventor
Heribert Schmitt-Willich
Tobias Heinrich
Damian Brockschnieder
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of AR080289A1 publication Critical patent/AR080289A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ARP110100377A 2010-02-08 2011-02-04 IODO PRECURSOR AGENT FOR OBTAINING PET IMAGES FROM AMYLOID PLATES AR080289A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10075054 2010-02-08

Publications (1)

Publication Number Publication Date
AR080289A1 true AR080289A1 (en) 2012-03-28

Family

ID=43645878

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP110100377A AR080289A1 (en) 2010-02-08 2011-02-04 IODO PRECURSOR AGENT FOR OBTAINING PET IMAGES FROM AMYLOID PLATES

Country Status (4)

Country Link
AR (1) AR080289A1 (en)
TW (1) TW201201846A (en)
UY (1) UY33218A (en)
WO (1) WO2011095593A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103724207B (en) * 2013-12-20 2016-07-06 北京智博高科生物技术有限公司 Phenylbenzyl ether derivative and its preparation method and application
EP3538161B1 (en) * 2016-11-08 2022-07-27 The Regents of The University of California Methods for multi-dose synthesis of [f-18]fddnp for clinical settings

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY27003A1 (en) * 2000-11-06 2002-07-31 Schering Ag RADIOPHARMACEUTICAL PRODUCTS FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE
EP2163541A1 (en) * 2008-09-12 2010-03-17 Bayer Schering Pharma Aktiengesellschaft Piperazine derivatives for binding and imaging amyloid plaques and their use

Also Published As

Publication number Publication date
TW201201846A (en) 2012-01-16
WO2011095593A1 (en) 2011-08-11
UY33218A (en) 2011-09-30

Similar Documents

Publication Publication Date Title
PT3051815T (en) IMAGE DECODING DEVICE
EP2579577A4 (en) X-RAY IMAGING DEVICE
PT2829881T (en) DIAGNOSIS FOR COLO-RECTAL CANCER
EP3525168C0 (en) VIRTUAL CEPHALOMETRIC IMAGING
BR112013010441A2 (en) inflammatory disease
BR112012019789A2 (en) methods and apparatus for synthesizing imaging agents and their intermediates
EP2756805A4 (en) ULTRASOUND IMAGING DEVICE
EP2528428A4 (en) EXTRUDED LITTERS FOR ANIMALS
FI20110104A7 (en) Arrangement for intraoral X-ray imaging
BR112012019497A2 (en) electromechanical brake apparatus
BR112013009605A2 (en) infectious disease alert system
PT2588067T (en) COMPOSITE FOR DENTAL HEALTH
EP2636359A4 (en) IMAGING DEVICE
BR112014004908A2 (en) medical device sanitizer
EP2735262A4 (en) IMAGING DEVICE
PL3657798T3 (en) METHOD OF DUAL REDUCTION OF THE IMAGE
PT3560937T (en) 18f-labeled psma-targeted pet imaging agents
EP2704416A4 (en) IMAGING DEVICE
ES2433591T8 (en) Device for cleaning interdental spaces
FI20105941A0 (en) Casting Materials
BRPI1008706A2 (en) device for diagnosis.
BR112013013929A2 (en) nanoparticle composition, and, processes for manufacturing a nanoparticle composition and diagnostic imaging
UY33152A (en) ADEQUATE FORMULATIONS FOR DIAGNOSIS FOR IMAGES WITH PET
DK2734834T3 (en) X-RAY IMAGING
CO6920300A2 (en) Dispersing agent for solid suspensions

Legal Events

Date Code Title Description
FB Suspension of granting procedure